- Category: V4 Mirror
Although V4 countries are rather partners than rivals for Baltics, there are some differences between both regions, such as in the case of euro, migration, democratic backsliding, security issues and approach towards Russia, said expert from the University of Tartu.
- Category: V4 Mirror
The most profound crisis facing the European Union today is the crisis of democracy in Central and Eastern Europe. Other EU crises such as the refugee crisis or the Eurozone crisis have – at least for the time being – abated, and Brexit has turned out to be more of a costly annoyance for the EU than the existential crisis many had feared. But the crisis of backsliding on the rule of law and democracy itself in some EU member states – particularly in Central and Eastern Europe – shows no signs of abating. Indeed, the situation is getting worse.
- Category: Articles
While the V4 are the main beneficiaries of EU subsidies, and the insufficient use of EU funds remains one of the most burning systemic issues the region is facing, the Visegrád Group is nowhere near unified on the issue. The EU’s anti-fraud agency has limited leverage, as it is up to local law enforcement authorities to investigate cases where EU funds were defrauded.
- Category: V4 Mirror
The political atmosphere for the protection of rule of law and other fundamental values of the European Union appears to be in a cautious but positive change. Instead of rallying around the flag, European political groups started putting greater leverage on national member parties that are not complying with European values.
Support
Partners
RSS - EURACTIV
-
The Brief, powered by EHFG — The rise of the kingmakers
With the new German parliament likely to be more fragmented after the federal election on Sunday (September 26), several small parties are preparing themselves to play a kingmaker role in the subsequent coalition-building talks.
-
EU Commission to buy up to 220,000 COVID anti-body treatments
The European Commission has signed a joint procurement framework contract with the pharmaceutical company Eli Lilly for the supply of monoclonal antibody treatment for coronavirus patients.
-
Illumina/GRAIL: Testing Vestager’s effort to expand EU merger control
The controversial $7.1 billion acquisition of GRAIL by Illumina is developing into a test of the European Commission’s new guidance on merger control, but also of the EU's competition chief Margrethe Vestager's resolve to expand the bloc's supervision of such mergers.